Age-related iron deposition in the basal ganglia: quantitative analysis in healthy subjects.

PURPOSE To determine the values of iron accumulation in the basal ganglia of healthy volunteers of different ages with R2* and raw signal intensity measurements from T1-weighted magnetic resonance (MR) images, supported by voxel-based relaxometry (VBR), and to compare them with previously reported iron concentrations found in autopsy material. MATERIALS AND METHODS The ethics committee approved the study, and the participants or their parents gave written informed consent. Eighty subjects (41 female and 39 male subjects; age range, 1-80 years) were examined at 1.5 T. For each subject, R2* values were calculated. Curves for R2* versus age were obtained for globus pallidus (GP), putamen, caudate nucleus, substantia nigra (SN), and frontal white matter (FWM). To highlight possible differences in iron concentration among the age decades, VBR was applied. Signal intensity values were estimated on T1-weighted fast low-angle shot images, and regions of interest were drawn in each nucleus. R2* values were also compared with iron concentrations reported in a postmortem study. Statistical analysis was performed (t test), and a difference with P < .05 (FDR corrected) was significant. RESULTS The curves for R2* versus age showed an exponential increase with increasing age in all the basal ganglia. VBR demonstrated significant differences (P < .05, corrected) in the comparison between the 2nd and the following decades for lenticular nuclei. Good correlation coefficients were found for GP (R(2) = 0.64), putamen (R(2) = 0.51), and SN (R(2) = 0.53) when compared with findings in the postmortem study. Signal intensity curves were similar to the R2* curves. CONCLUSION R2* measurements can be used to quantify brain iron accumulation and thus may allow better evaluation of neurodegenerative diseases associated with iron deposition.

[1]  Patrice Péran,et al.  Voxel‐based analysis of R2* maps in the healthy human brain , 2007, Journal of magnetic resonance imaging : JMRI.

[2]  Koichi Oshio,et al.  Spatially selective T2 and T2 * measurement with line-scan echo-planar spectroscopic imaging. , 2004, Journal of magnetic resonance.

[3]  Nathalie Boddaert,et al.  Selective iron chelation in Friedreich ataxia: biologic and clinical implications. , 2007, Blood.

[4]  R A Knight,et al.  MR imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content. , 1999, Radiology.

[5]  M. Grisoli,et al.  Role of CT and MRI in Diagnosis and Research , 2005 .

[6]  R. Brooks,et al.  T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content. , 1999, Radiology.

[7]  Jim Mintz,et al.  Brain ferritin iron may influence age- and gender-related risks of neurodegeneration , 2007, Neurobiology of Aging.

[8]  J. Connor,et al.  Iron, brain ageing and neurodegenerative disorders , 2004, Nature Reviews Neuroscience.

[9]  Karl J. Friston,et al.  A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains , 2001, NeuroImage.

[10]  G. Bartzokis,et al.  In vivo MR evaluation of age-related increases in brain iron. , 1994, AJNR. American journal of neuroradiology.

[11]  G A Johnson,et al.  MRI of brain iron. , 1986, AJR. American journal of roentgenology.

[12]  R. Martins,et al.  Quantitative MR imaging R2 relaxometry in elderly participants reporting memory loss. , 2006, AJNR. American journal of neuroradiology.

[13]  B. Drayer Basal ganglia: significance of signal hypointensity on T2-weighted MR images. , 1989, Radiology.

[14]  R A Brooks,et al.  Role of iron and ferritin in MR imaging of the brain: a study in primates at different field strengths. , 1990, Radiology.

[15]  L. Ketonen Neuroimaging of the aging brain. , 1998, Neurologic clinics.

[16]  Jim M Wild,et al.  Multiple gradient echo sequence optimized for rapid, single‐scan mapping of R  2* at high B0 , 2002, Magnetic resonance in medicine.

[17]  A. Koeppen A brief history of brain iron research , 2003, Journal of the Neurological Sciences.

[18]  Daniela Berg,et al.  Role of Iron in Neurodegenerative Disorders , 2006, Topics in magnetic resonance imaging : TMRI.

[19]  F. Ye,et al.  Increasing striatal iron content associated with normal aging , 1998, Movement disorders : official journal of the Movement Disorder Society.

[20]  D. Kido,et al.  Mineralization of the Deep Gray Matter with Age: A Retrospective Review with Susceptibility-Weighted MR Imaging , 2008, American Journal of Neuroradiology.

[21]  Tobias Schaeffter,et al.  R2 and R2* mapping for sensing cell-bound superparamagnetic nanoparticles: in vitro and murine in vivo testing. , 2007, Radiology.

[22]  F. Ye,et al.  Basal ganglia iron content in Parkinson's disease measured with magnetic resonance , 1996, Movement disorders : official journal of the Movement Disorder Society.

[23]  Gaby S Pell,et al.  Voxel-based relaxometry: a new approach for analysis of T2 relaxometry changes in epilepsy , 2004, NeuroImage.

[24]  Michael Forsting,et al.  Age-related changes of the dentate nuclei in normal adults as revealed by 3D fast low angle shot (FLASH) echo sequence magnetic resonance imaging , 2004, Journal of Neurology.

[25]  Rohit Bakshi,et al.  Magnetic Resonance Imaging of Iron Deposition in Neurological Disorders , 2006, Topics in magnetic resonance imaging : TMRI.

[26]  J. Bulte,et al.  Microscopic R2* mapping of reduced brain iron in the Belgrade rat , 2002, Annals of neurology.

[27]  A J Barkovich,et al.  Normal deposition of brain iron in childhood and adolescence: MR imaging at 1.5 T. , 1989, Radiology.

[28]  B. Drayer,et al.  Imaging of the aging brain. Part I. Normal findings. , 1988, Radiology.

[29]  John F. Schenck,et al.  Imaging of brain iron by magnetic resonance: T2 relaxation at different field strengths , 1995, Journal of the Neurological Sciences.

[30]  S W Atlas,et al.  Deep gray matter hypointensity patterns with aging in healthy adults: MR imaging at 1.5 T. , 1991, Radiology.

[31]  Hisashi Tanaka,et al.  Determination of transverse relaxation rate for estimating iron deposits in central nervous system , 2005, Neuroscience Research.

[32]  W H Oldendorf,et al.  Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores , 1993, Magnetic resonance in medicine.

[33]  G. Bartzokis,et al.  Brain Ferritin Iron as a Risk Factor for Age at Onset in Neurodegenerative Diseases , 2004 .

[34]  J. Gutteridge,et al.  Iron and oxygen radicals in tissue damage: implications for the neuronal ceroid lipofuscinoses , 1983, Acta neurologica Scandinavica.

[35]  J. Connor,et al.  Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains , 1990, Journal of neuroscience research.

[36]  P. Boesiger,et al.  Age distribution and iron dependency of the T2 relaxation time in the globus pallidus and putamen , 2004, Neuroradiology.

[37]  H. Miyajima Aceruloplasminemia, an iron metabolic disorder , 2003, Neuropathology : official journal of the Japanese Society of Neuropathology.

[38]  David Katz,et al.  The relation between brain iron and NMR relaxation times: An in vitro study , 1996, Magnetic resonance in medicine.

[39]  E. Haacke,et al.  Imaging iron stores in the brain using magnetic resonance imaging. , 2005, Magnetic resonance imaging.

[40]  R. Switzer,et al.  The regional distribution and cellular localization of iron in the rat brain , 1984, Neuroscience.

[41]  John F Schenck,et al.  Magnetic resonance imaging of brain iron , 2003, Journal of the Neurological Sciences.

[42]  P D Griffiths,et al.  Iron in the basal ganglia in Parkinson's disease. An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy. , 1999, Brain : a journal of neurology.

[43]  B. Levinson,et al.  Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. , 2003, The New England journal of medicine.

[44]  B. Hallgren,et al.  THE EFFECT OF AGE ON THE NON‐HAEMIN IRON IN THE HUMAN BRAIN , 1958, Journal of neurochemistry.